➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Johnson and Johnson
Boehringer Ingelheim
Merck

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Galderma Laboratories LP v. Tolmar Inc. (D. Del. 2010)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Galderma Laboratories LP v. Tolmar Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Galderma Laboratories LP v. Tolmar Inc. (D. Del. 2010)

Date Filed Document No. Description Snippet Link To Document
2011-08-08 176 Notice of Service Relating to the Unenforceability of U.S. Patent Nos. 7,579,377, 7,737,181, 7,834,060, 7,838,558, and 7,… Ph.D. Relating to the Validity of U.S. Patent Nos. 7,579,377, 7,737,181, 7,834,060, 7,838,558, and 7,…Clinical Study Information Relative to the Asserted Patent Claims; 3) Opening Expert Report of Russell O. … M.D. Relating to the Validity of the Asserted Patents by Tolmar Inc..(Keller, Karen) 8 August 2011…2010 24 September 2012 1:10-cv-00045 Patent District Court, D. Delaware D External link to document
2010-11-08 24 Notice of Service Galderma's Identified Terms of U.S. Patent No. 7,579,377 (the 377 patent) by Tolmar Inc..(Keller, Karen) …2010 24 September 2012 1:10-cv-00045 Patent District Court, D. Delaware D External link to document
2010-12-20 26 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,737,181 B2;. (Noreika, Maryellen…2010 24 September 2012 1:10-cv-00045 Patent District Court, D. Delaware D External link to document
2012-02-13 289 Memorandum Opinion infringe the five patents-in-suit: U.S. Patent Nos. 7,579,377 ("the '377 patent"), 7,737,…377 patent, col. 2ll. 4-9; '060 patent, col. 2ll. 24-29) (emphasis added) Plainly, the patent is …and 34; '558 patent, claims 4 and 7; '181 patent, claims 2-5; '044 patent, claims …;558 patent, claims 4, 6, and 7; '181 patent, claims 3 and 36; '044 patent, claims…quot; ('377 patent, col. 3 11. 2-4; '558 patent, col. 3 ll. 24-26; '060 patent, col. 3 ll. External link to document
2012-09-11 335 Opinion States Patent Nos. 7,579,377 ("the '377 patent"); 7,737,181 ("the '181 patent"… 1. Shroot Patents: '720 Patent (1988), '895 Patent (1992), and '440 …Galderma patents-in-suit asserted against Tolmar at trial (the '181 patent, the '044 patent, the … The '181 patent is terminally disclaimed to the '3 77 patent, U.S. Patent No. 7,642,288, … The '060 patent is terminally disclaimed to the '377 patent, U.S. Patent No. 7,642,288, and External link to document
2012-09-24 341 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,377 B2; 7,737,181 B2; 7,834,060…2010 24 September 2012 1:10-cv-00045 Patent District Court, D. Delaware D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
McKinsey
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.